PACIO Personal Functioning and Engagement Implementation Guide
2.0.0 - STU 2 United States of America flag

This page is part of the PACIO Personal Functioning and Engagement Implementation Guide (v2.0.0: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example AllergyIntolerance: PFEIG-AllergyACE

Page standards status: Informative

clinicalStatus: Active

verificationStatus: Confirmed

category: Medication

criticality: High Risk

code: Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)

patient: Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)

asserter: Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)

lastOccurrence: 2011-10

Reactions

-SubstanceManifestation
*captopril 12.5 MG Oral TabletHyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)